Device-Related Thrombosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Device-Related Thrombosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06523166

Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics

The current standard of care for patients who underwent left atrial appendage closure (LAAC) is to have follow-up transesophageal echocardiogram (TEE) for devic…

United States320 participantsStarted 2026-03-27

Treatment: Transesophageal echocardiography (TEE), Cardiac CTA

All recent trials (20 shown)

Not Yet RecruitingNot Applicable

NCT06177704

Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study

This study is a prospective, multicenter international trial aimed at assessing the actual incidence, identifying associated factors, and evaluating the clinica…

Canada100 participantsStarted 2026-12-01

Active — Not RecruitingPhase 3

NCT05825573

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

Left ventricular thrombus is found in 10 to 25% of patients with impaired left ventricular function following ST-segment elevation myocardial infarction and up…

France340 participantsStarted 2023-05-15

Treatment: Vitamin K antagonist, Direct oral anticoagulant

Device-Related Thrombosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics

All recent trials (20 shown)

Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics

All recent trials (20 shown)

Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Clo…

Incidence of Complications of Peripheral Venous Access in the Type 2 Diabetic Population

APPEND-CT Registry

Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvu…

Complications Related to Vascular Access Devices in Home Parenteral Nutrition Patients

Pulse Wave Analysis in Advanced Heart Failure

A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD

PREMO Study: to Investigate Port REMoval Outcomes

Platelet-activation and Optimal Inhibition in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusi…

Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial…

Prophylactic Anticoagulation for Catheter-related Thrombosis

e-BioMatrix Canada Registry

SCD Use to Prevent Deep Venous Thrombosis (DVT) in Patients With PICC Lines

Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers

Comparison Between Sutureless Devices for PICC and a New System KT FIX PLUS

Angel® Catheter Post Market Registry

Cystic Fibrosis and Totally Implantable Vascular Access Devices